General Information of the Compound
| Compound ID |
CP0529102
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-bromo-N-(6-methylpyridin-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3-bromophenyl)-N-(6-methyl(2-pyridyl))carboxamide
188747-28-6
3-Bromo-N-(6-methyl-2-pyridinyl)benzamide #
3-Bromo-N-(6-methyl-pyridin-2-yl)-benzamide
3-bromo-N-(6-methylpyridin-2-yl)benzamide
3-bromo-N~1~-(6-methyl-2-pyridyl)benzamide
AC1LCNCE
AKOS000204447
BDBM50186324
BOCBDQIZNZCOPX-UHFFFAOYSA-N
Benzamide, 3-bromo-N-(6-methyl-2-pyridinyl)-
CHEMBL377195
CTK0A3803
DTXSID30345279
HMS1540H09
MCULE-1961959863
MolPort-002-316-872
Oprea1_606042
ST031112
STK182187
TimTec1_002275
Z57716131
ZINC138486
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H11BrN2O
|
||||||||||||||||||
| Molecular Weight |
291.148
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(NC(=O)c2cccc(Br)c2)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H11BrN2O/c1-9-4-2-7-12(15-9)16-13(17)10-5-3-6-11(14)8-10/h2-8H,1H3,(H,15,16,17)
Show/Hide
|
||||||||||||||||||
| InChIKey |
BOCBDQIZNZCOPX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound